Cargando…
Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells
INTRODUCTION: The taxanes paclitaxel and docetaxel are widely used in the treatment of breast, ovarian, and other cancers. Although their cytotoxicity has been attributed to cell-cycle arrest through stabilization of microtubules, the mechanisms by which tumor cells die remains unclear. Paclitaxel h...
Autores principales: | Sprowl, Jason A, Reed, Kerry, Armstrong, Stephen R, Lanner, Carita, Guo, Baoqing, Kalatskaya, Irina, Stein, Lincoln, Hembruff, Stacey L, Tam, Adam, Parissenti, Amadeo M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496117/ https://www.ncbi.nlm.nih.gov/pubmed/22225778 http://dx.doi.org/10.1186/bcr3083 |
Ejemplares similares
-
Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel
por: Armstrong, Stephen R, et al.
Publicado: (2012) -
Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance
por: Edwardson, Derek W., et al.
Publicado: (2017) -
Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance
por: Hembruff, Stacey L, et al.
Publicado: (2008) -
Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells
por: Chewchuk, Simon, et al.
Publicado: (2017) -
Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells
por: Guo, Baoqing, et al.
Publicado: (2016)